Product Description
Overall, the global nebulizer market was valued at $310 million in 2023. This is expected to increase over the forecast period to reach nearly $446 million.
The majority of the global nebulizer market share was controlled by Omron, Drive DeVilbiss, and Philips Healthcare.
A nebulizer is a piece of equipment used to assist breathing when the lung is affected by diseases such as asthma, cystic fibrosis, and other respiratory conditions. The market for nebulizers typically corresponds to the delivery of asthma medications to anyone who has difficulty using a standard asthma inhaler. This global market research spans over 70 countries and includes compressor/jet nebulizers and vibrating nebulizers.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL NEBULIZER MARKET INSIGHTS
GLOBAL NEBULIZER MARKET SHARE INSIGHTS
Omron led the nebulizer market, known for its ultrasonic and vibrating mesh nebulizers like the compact Micro Air® NE-U100. Their portfolio includes the quiet NE-C801 compressor and the versatile CompAir® series. In 2020, Omron introduced a child-friendly CompAir® design.
Drive DeVilbiss ranked second with its array of jet compressors and handheld nebulizers, particularly the UltraNeb™ ultrasonic nebulizer known for its adjustable airflow and versatility. The company also offers the AirForce and PulmoAide compressor nebulizers.
Philips features portable nebulizers in its Inspiration® and InnoSpire® lines, like the lightweight Inspiration® 626 and Elite models, and the compact InnoSpire® Essence. The InnoSpire® Go stands out as the smallest, lightest portable mesh nebulizer available.
Market Segmentation Summary
- Compressor/Jet Nebulizer – Includes:
- Stationary and portable.
- Vibrating Nebulizer – Includes:
- Ultrasonic and vibrating mesh.
Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |